KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Interest & Investment Income: 2017-2024

Historic Interest & Investment Income for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to $709.5 million.

  • BioNTech SE's Interest & Investment Income fell 34.03% to $113.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $538.0 million, marking a year-over-year decrease of 25.52%. This contributed to the annual value of $709.5 million for FY2024, which is 26.92% up from last year.
  • According to the latest figures from FY2024, BioNTech SE's Interest & Investment Income is $709.5 million, which was up 26.92% from $559.1 million recorded in FY2023.
  • BioNTech SE's 5-year Interest & Investment Income high stood at $709.5 million for FY2024, and its period low was $1.9 million during FY2020.
  • Its 3-year average for Interest & Investment Income is $535.2 million, with a median of $559.1 million in 2023.
  • As far as peak fluctuations go, BioNTech SE's Interest & Investment Income plummeted by 57.96% in 2020, and later spiked by 3,959.77% in 2021.
  • Over the past 5 years, BioNTech SE's Interest & Investment Income (Yearly) stood at $1.9 million in 2020, then surged by 3,959.77% to $77.4 million in 2021, then spiked by 335.12% to $337.0 million in 2022, then soared by 65.90% to $559.1 million in 2023, then rose by 26.92% to $709.5 million in 2024.